Microbial etiology of bacterial chronic prostatitis: systematic review
Authors:
- Raúl Mendoza-RodríguezRMRaúl Mendoza-Rodríguez
- Itahisa Hernández-ChicoIHItahisa Hernández-Chico
- Blanca Gutiérrez-SotoBGBlanca Gutiérrez-Soto
- José María Navarro-MaríJNJosé María Navarro-Marí
- José Gutiérrez-FernándezJosé Gutiérrez-Fernández
- 9 January 2023
- journal article
- review article
- Published by Sociedad Espanola de Quimioterapia in Revista Española de Quimioterapia
- Vol. 36 (2) , 144-151
Abstract
Objectives. The importance of Gram-positive microorganisms and atypical bacteria in chronic bacterial prostatitis (CBP) has recently been described. For this reason, this study analyzes the etiology of CBP, as well as the evolution of antibiotic resistance through a systematic review. Material and methods. A systematic review of studies obtained through the MEDLINE (PubMed) database, related to the etiology and antibiotic resistance profile of CBP, published up July 1, 2021. Results. The most frequent isolated microorganisms that we have found in publications are Enterococcus faecalis (46.90%), Staphylococcus spp. (22.30%), Escherichia coli (15.09%) and atypical bacteria (6.04%). Conclusions. CBP is undergoing and unprecedented change of paradigm. Gram-positive bacteria and atypical bacteria are the main pathogens involved in the aetiology of this entity. This forces us to rethink the therapeutic strategy used, since it is necessary to use antibiotics that assume the etiological change and the profile of antibiotic resistance described.Keywords
This publication has 48 references indexed in Scilit:
- Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in KoreaProstate International, 2013
- Antimicrobial Resistance Pattern inEnterococcus faecalisStrains Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial ProstatitisKorean Journal of Urology, 2013
- Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance StudyAntimicrobial Agents and Chemotherapy, 2011
- Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcificationsFEMS Immunology & Medical Microbiology, 2010
- Treatment of Bacterial ProstatitisClinical Infectious Diseases, 2010
- May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection?Andrologia, 2010
- Management of bacterial prostatitis: what’s new?BJU International, 2008
- Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400mg to healthy volunteersInternational Journal of Antimicrobial Agents, 2008
- Current challenges in the treatment of complicated urinary tract infections and prostatitisClinical Microbiology and Infection, 2006
- The role of unusual pathogens in prostatitis syndromeInternational Journal of Antimicrobial Agents, 2004